Quality Control Associate II, Controls
Capricor Therapeutics
About this role
A Quality Control Associate II, Controls at Capricor Therapeutics supports the development, qualification, and lifecycle management of analytical control materials used in QC assays. The role involves generating and maintaining positive and negative controls, performing analytical studies, and supporting troubleshooting and optimization of analytical methods.
Skills
Qualifications
About Capricor Therapeutics
capricor.comCapricor Therapeutics, Inc. (NASDAQ: CAPR) is a San Diego–based biotechnology company developing cell- and exosome-based therapeutics for muscular and other select diseases. Its lead candidate, deramiocel (CAP‑1002), is an allogeneic cell therapy currently in Phase 3 clinical development for Duchenne muscular dystrophy. Capricor is also advancing exosome technology as a next‑generation platform, engineering exosomes to deliver nucleic acids and proteins to treat or prevent a variety of diseases. The company focuses on translating these platforms into novel therapeutic and preventive products.
Recent company news
GuruFocusCapricor Therapeutics (CAPR) Shares Recommended for Purchase Ami
18 minutes ago
BenzingaCapricor Therapeutics Stock Slides As Q4 Earnings Miss Estimates
2 hours ago
marketscreener.comCapricor Therapeutics Falls on Wider-Than-Expected 4Q Loss
34 minutes ago
Stock TitanDuchenne trial drug from Capricor slows key task decline 83%
23 hours ago
MarketBeatCapricor Therapeutics Q4 Earnings Call Highlights
21 hours ago
About Capricor Therapeutics
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Capricor Therapeutics.